Literature DB >> 16532323

Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus.

E Bonora1, G Corrao, V Bagnardi, A Ceriello, M Comaschi, P Montanari, J B Meigs.   

Abstract

AIMS/HYPOTHESIS: Post-prandial glucose may be a risk factor for cardiovascular disease and chronic diabetic complications. We tested the hypothesis that post-prandial hyperglycaemia is common in type 2 diabetes, even among patients in apparently good glycaemic control, and that simple clinical characteristics identify subsets of diabetic patients with frequent post-prandial hyperglycaemia. SUBJECTS AND METHODS: Three self-assessed daily blood glucose profiles over a 1-week period, including 18 glucose readings before and 2 h after meals, were obtained from 3,284 unselected outpatients (men 51%; age 63+/-10 years) with non-insulin-treated type 2 diabetes mellitus attending 500 different diabetes clinics operating throughout Italy.
RESULTS: A post-prandial blood glucose value >8.89 mmol/l (160 mg/dl) was recorded at least once in 84% of patients, and 81% of patients had at least one Delta glucose > or =2.22 mmol/l (40 mg/dl). Among patients with apparently good metabolic control, 38% had >40% of post-prandial blood glucose readings >8.89 mmol/l (> or =4 of 9 meals in total), and 36% had >40% Delta glucose > or =2.22 mmol/l. In multivariate analysis adjusted for pre-prandial glucose levels, older age, longer duration of diabetes, absence of obesity, hyperlipidaemia and hypertension, as well as treatment with sulfonylureas, were significantly associated with greater glucose excursions after meals. CONCLUSIONS/
INTERPRETATION: These results indicate that post-prandial hyperglycaemia is a very frequent phenomenon in patients with type 2 diabetes mellitus on active treatment; can occur even when metabolic control is apparently good; and can be predicted by simple clinical features.

Entities:  

Mesh:

Year:  2006        PMID: 16532323     DOI: 10.1007/s00125-006-0203-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  45 in total

1.  Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.

Authors:  M Hanefeld; S Fischer; U Julius; J Schulze; U Schwanebeck; H Schmechel; H J Ziegelasch; J Lindner
Journal:  Diabetologia       Date:  1996-12       Impact factor: 10.122

2.  Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.

Authors:  E Bonora; F Calcaterra; S Lombardi; N Bonfante; G Formentini; R C Bonadonna; M Muggeo
Journal:  Diabetes Care       Date:  2001-12       Impact factor: 19.112

3.  Endothelium-dependent flow-mediated vasodilation in the postprandial state in type 2 diabetes mellitus.

Authors:  H Shige; T Ishikawa; M Suzukawa; T Ito; K Nakajima; K Higashi; M Ayaori; S Tabata; F Ohsuzu; H Nakamura
Journal:  Am J Cardiol       Date:  1999-11-15       Impact factor: 2.778

4.  Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.

Authors:  H Kawano; T Motoyama; O Hirashima; N Hirai; Y Miyao; T Sakamoto; K Kugiyama; H Ogawa; H Yasue
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

5.  Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166).

Authors:  F M Gribble; S E Manley; J C Levy
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

6.  Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia.

Authors:  R Marfella; K Esposito; R Giunta; G Coppola; L De Angelis; B Farzati; G Paolisso; D Giugliano
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

7.  Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.

Authors:  C Abraira; J Colwell; F Nuttall; C T Sawin; W Henderson; J P Comstock; N V Emanuele; S R Levin; I Pacold; H S Lee
Journal:  Arch Intern Med       Date:  1997-01-27

8.  Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

Authors:  M Shichiri; H Kishikawa; Y Ohkubo; N Wake
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

9.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

10.  Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay.

Authors:  Janet B McGill; Thomas G Cole; William Nowatzke; Shannon Houghton; Erika B Ammirati; Theresa Gautille; Mark J Sarno
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

View more
  32 in total

1.  Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal.

Authors:  David A Zhang; Laurence Katznelson; Ming Li
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

2.  Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes.

Authors:  Christopher G Parkin; Jaime A Davidson
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

Review 3.  Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making.

Authors:  Gerhard H Scholz; Holger Fleischmann
Journal:  Ther Adv Endocrinol Metab       Date:  2014-10       Impact factor: 3.565

4.  Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates.

Authors:  Siming Liu; Mikako Harata; Joseph A Promes; Anthony J Burand; James A Ankrum; Yumi Imai
Journal:  J Vis Exp       Date:  2019-05-14       Impact factor: 1.355

5.  Prolonged Nightly Fasting and Breast Cancer Risk: Findings from NHANES (2009-2010).

Authors:  Catherine R Marinac; Loki Natarajan; Dorothy D Sears; Linda C Gallo; Sheri J Hartman; Elva Arredondo; Ruth E Patterson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04-20       Impact factor: 4.254

6.  International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece.

Authors:  Geremia B Bolli; Larry C Deeb; Satish K Garg; John L Leahy; Roger S Mazze; David R Owens; Matthew C Riddle; Phil Southerland; Ellie S Strock
Journal:  Diabetes Technol Ther       Date:  2011-09       Impact factor: 6.118

7.  Lowering physical activity impairs glycemic control in healthy volunteers.

Authors:  Catherine R Mikus; Douglas J Oberlin; Jessica L Libla; Angelina M Taylor; Frank W Booth; John P Thyfault
Journal:  Med Sci Sports Exerc       Date:  2012-02       Impact factor: 5.411

8.  Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion.

Authors:  Tina K Thethi; Ajay Rao; Haytham Kawji; Tilak Mallik; C Lillian Yau; Uwe Christians; Vivian Fonseca
Journal:  J Diabetes Complications       Date:  2009-04-23       Impact factor: 2.852

Review 9.  Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach.

Authors:  James H O'Keefe; Maia D Carter; Carl J Lavie
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

10.  Targeting prandial hyperglycemia: how important is it and how best to do this?

Authors:  Louis Monnier; Claude Colette
Journal:  Curr Diab Rep       Date:  2008-10       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.